NETTER P: A Multi-Center, Open Label Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients with Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors, Pheochromocytoma and Paragangliomas

Grants and Contracts Details

StatusActive
Effective start/end date12/1/215/23/25

Funding

  • Advanced Accelerator Applications SA: $84,782.00